Home
Company
About us
Management
Board of Directors
Scientific Advisory Board
Partnerships
Partnerships
Nox Science
NOX Enzymes
NADPH Oxidase
NOX Enzyme Family
NOX Expression
NOX and Disease
Oxidative Stress and Disease
Physiological Functions of NOX
Fibrotic diseases
Neurodegenerative diseases
Cardiovascular diseases
Publications
Pipeline
GKT831
GKT771
Research programs
Investors
Message from the CEO
Stock information
Analyst coverage
Contribution project
Press release
Project presentation
Documentation
Shareholders general meeting
Press releases
2018
2017
2016
2015
2014
Events and presentations
Regulated information
Financial information
2018
2017
2016
2015
2014
Other regulated information
2018
2017
2016
2015
2014
Governance
Shareholder information
Shareholders’ meetings
2018
2017
AGM of June 15, 2017
AGM of February 28, 2017
2016
2015
2014
Agenda
News and Events
Press releases
2018
2017
2016
2015
2014
Events and presentations
Media
Press clippings
Interviews
Contacts
News
See all news
Prev
Next
2018-06-25 - 07:00
Genkyotex Expands License Agreement for Vaxiclase Platform with Serum ...
2018-05-07 - 07:00
Genkyotex announces positive outcome from ISMB's first review of GKT83...
2018-04-25 - 17:45
Genkyotex reports March 31, 2018 cash position and provides business u...
2018-04-09 - 09:00
Genkyotex to Present Corporate Overview at H. C. Wainwright Annual Glo...
2018-03-12 - 17:45
Genkyotex to Present Corporate Overview at 30th Annual ROTH Conference
2018-02-28 - 17:45
Genkyotex Announces 2017 Annual Financial Results
2018-02-20 - 18:00
Genkyotex's Lead Product Candidate, GKT831, Halts the Tumor Promoting ...
2018-01-31 - 18:00
Genkyotex reports December 31, 2017 cash position and provides busines...
Events
See all events
2018-02-09 - 09:00
Investor Presentation June 2018
